RxDoctor Payments Data

John Nemunaitis

Medical Oncology · Toledo, OHNPI 1164464269

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,575 of the $1,640 with a category attached, or 96.1%. AstraZeneca accounts for 96.1% of it on its own, with 3 other manufacturers making up the rest. That places this record below the midpoint for medical oncology clinicians in OH, where the typical reported total is $2,659.

$1,640in general payments, 2019–2025

Across 4 payments — averaging $409.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • Tempus AI, Inc$36
  • Merck$15
  • Varian Medical Systems, Inc.$13
$1,651,720in research payments, 2019–2025

Across 233 payments — averaging $7088.93 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$667K
  • Anaeropahrma Science, Inc.$301K
  • Servier Bioinnovation$144K
  • Eli Lilly$134K
  • Daiichi Sankyo Inc.$81K
  • Genentech, Inc.$69K
  • plus $256K from 12 others

What the payments were for

  • Consulting fees$1,57596%
  • Food & beverage$654%

General payments by program year

19
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca1$1,575
Tempus AI, Inc1$36
Merck1$15
Varian Medical Systems, Inc.1$13

How this compares

$1,640 in reported general payments places this provider in the 40th percentile of 157 medical oncology providers in Ohio.

See all medical oncology providers in Ohio

Other medical oncology in Toledo

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →